Arkema and Australian company Chemeq Technologies are pleased to announce the signing of a manufacturing cooperation agreement for the supply by Arkema of a new antimicrobial polymer.
As a result, Chemeq Technologies will be able to offer its industrial customers in the cosmetics and pharmaceuticals sector a solution that is in keeping with a sustainable development approach, marketed under the tradename Cereese.
Chemeq Technologies also has plans to market its technology in a range of other industrial and medical products.
For the cosmetics industry, Cereese is a breakthrough antimicrobial that is non-toxic and generally safer than most current preservatives and actives on the market, and has broad spectrum activity against bacteria, viruses and fungi. Recent clinical studies have shown Cereese to be effective against acne- and dandruff-causing bacteria. Due to Cereese’s polymeric nature and the molecule’s size, absorption through the skin is inhibited, a particularly useful property for cosmetics applications.
Bacteria now seem to be showing growing resistance to common antibiotics and biocides. The technology based on the use of this antimicrobial polymer offers an effective solution to counteract the development of such resistance.
The production of this new polymer falls in line with Arkema’s strategy to step up the use of renewable raw materials.
A global chemical company and France’s leading chemicals producer, Arkema consists of three businesses: Vinyl Products, Industrial Chemicals, and Performance Products. Arkema reports sales of 5.6 billion euros. Arkema has 15,000 employees in over 40 countries and six research centers located in France, the United States and Japan. With internationally recognized brands, Arkema holds leadership positions in its principal markets.